A comprehensive guide to selecting the right contract research organization for clinical trials in Latin America, covering regulatory expertise, site networks, cost comparisons, and key evaluation criteria for 2026.
Why Latin America Has Become the Go-To Region for Clinical Trials Latin America has emerged as one of the most compelling regions for conducting clinical trials, particularly for MedTech, biopharma, and radiopharma companies seeking faster timelines and lower costs. With regulatory agencies across 10+ countries streamlining approval processes, ethics committee approvals can be achieved in as little as 4–8 weeks — compared to 6–12 months in the US or EU. The region offers treatment-naive patient populations, world-class investigators, and per-patient costs that are 30–50% lower than equivalent US/EU studies. Countries like Colombia, Brazil, Mexico, Argentina, Chile, Peru, Panama, and Ecuador each offer distinct regulatory advantages depending on your device class, therapeutic area, and trial phase. What to Look for in a LATAM CRO Choosing the right contract research organization (CRO) for Latin America requires evaluating several critical factors that differ fro…